Who Is a Candidate for TMS? Why Implants, Metal in the Head and Seizure History Matter

The clipboard stops her at question four. “Do you have any metal or electronic devices in your head, neck or upper body?” She thinks about the two crowns on her molars, the titanium screw from a sinus surgery years ago, and the pacemaker her father wears. Which of those count? The woman filling in that form is not unusual. Most people who ask about transcranial magnetic stimulation, or TMS, arrive knowing more about what it treats than about who can safely have it.

That gap matters, because TMS candidacy, metal implants and seizure history are bound together by physics rather than paperwork. A TMS coil creates a rapidly changing magnetic field, and anything conductive or electronic close to it can heat, shift or misfire. The brain itself can, very rarely, respond with a seizure. Screening exists to catch those risks before the first pulse.

This explainer walks through how the procedure works, why certain implants are a firm no while others earn a shrug, what the evidence says about seizures, and which questions are worth asking before you sit in the chair.

What actually happens during a TMS session?

Transcranial magnetic stimulation is a non-surgical treatment in which an insulated coil resting against the scalp delivers short magnetic pulses that pass through the skull and induce small electrical currents in the outer layer of the brain, called the cortex. Nothing is implanted, no anesthesia is used, and you stay awake the entire time.

The first visit is mostly measurement. The clinician places the coil over the part of the brain that controls hand movement and slowly increases pulse intensity until your thumb twitches. That twitch defines your motor threshold, the lowest intensity that produces a visible response, and every later session is set relative to it. The coil is then moved forward to the treatment target, which for depression is usually the left dorsolateral prefrontal cortex, a region above and slightly in front of the temple involved in mood and decision-making.

Once treatment begins, you sit in a reclining chair wearing earplugs. Each pulse makes a loud click and a tapping sensation on the scalp, a bit like being flicked with a fingertip in a steady rhythm. Sessions typically last 20 to 40 minutes, according to the Cleveland Clinic, and a standard course runs five days a week for roughly four to six weeks, according to the Mayo Clinic. You can talk to staff during treatment and normally drive yourself home afterward.

The magnetic field is roughly as strong as an MRI scanner’s, but it exists only for a fraction of a millisecond at a time and reaches only a few centimeters beneath the scalp. That combination, strong yet brief and shallow, is exactly why the implant and seizure questions on the screening form are not box-ticking exercises but the core of deciding who can have TMS at all.

TMS candidacy and metal implants: why the coil location is the first screening question

Every conductor placed inside a changing magnetic field develops an electrical current. That is the same law of physics that makes TMS work on brain tissue, and it does not switch off for a surgical clip or a wire. Three separate hazards follow from it.

The first is movement. Ferromagnetic metal, meaning metal that a magnet pulls on, such as ordinary steel, can be tugged by each pulse. A tiny tug does not matter in a hip, but a clip sitting on a brain artery is another matter entirely. The second is heating. Induced currents warm metal, and a heated object against nerve or brain tissue can cause a burn. The third is malfunction. Electronic devices can be reprogrammed, reset or damaged when their circuits pick up the pulse.

Distance is the deciding variable. Field strength falls away sharply with every centimeter from the coil, which is why the international TMS safety guidelines published by Rossi and colleagues, and the screening questionnaires derived from them, focus on metal in the head and on any device within roughly 30 centimeters of the coil, in practice the head, neck and upper chest. A knee replacement is not a concern for a coil over the forehead. A stimulator wire tunneled up the neck may be.

Material matters too. Titanium and most modern surgical alloys are not ferromagnetic, so a titanium plate will not be pulled, though heating still has to be considered. Dental fillings, crowns and standard braces are generally acceptable, according to the Mayo Clinic, because they are small, fixed and sit well below the treatment site. This is why the honest answer to “Does my implant disqualify me?” is almost always “Which one, what is it made of, and exactly where is it?”

TMS contraindications: which implants are usually a hard no, and which get a case-by-case review

A contraindication is a condition or circumstance that makes a treatment unsafe. In TMS practice, clinicians tend to sort implants into three tiers: usually excluded, discussed individually, and usually fine. The table below summarizes the approach most programs take, drawing on the Mayo Clinic, Cleveland Clinic and international safety guidelines. It is a map for conversation, not a verdict; your team makes the call with your surgical records in hand.

Implant or device	Usual approach	Main concern
Aneurysm clips or coils in the brain	Usually excluded	Movement of ferromagnetic clip; heating
Cochlear implants	Usually excluded	Device damage; internal magnet sits under scalp
Deep brain stimulation or vagus nerve stimulator	Usually excluded unless in a supervised program	Induced current in electrodes and leads
Pacemaker or implantable defibrillator	Usually excluded or needs cardiology review	Device reprogramming or malfunction
Metal plates, screws or mesh from skull or facial surgery	Case by case	Depends on material, size and distance from coil
Bullet fragments, shrapnel or metal from an injury	Case by case, often excluded if in the head	Unknown composition; possible movement
Stents or clips in neck or chest	Case by case	Distance from coil; material
Permanent makeup or tattoos with metallic pigment near the head	Case by case	Skin heating or discomfort
Dental fillings, crowns, standard braces	Usually fine	Minimal; far from treatment site
Joint replacements below the shoulders	Usually fine	Too distant for meaningful field exposure

Two practical notes follow. First, bring documentation: an operative report or implant card tells the team the exact alloy and location far better than memory can. Second, “excluded” is not always permanent. Some stimulator systems can be switched off and some clips are confirmed non-magnetic, which shifts a case from the first tier to the second.

TMS and seizure history: what the evidence actually shows

A seizure is a burst of abnormal, synchronized electrical activity in the brain. Because TMS deliberately induces electrical activity, seizure is its most serious recognized adverse effect, and it is worth being precise about how often it happens and to whom.

The international safety guidelines first published in 2009 and later updated describe TMS-induced seizure as rare, with an estimated crude risk below 1 percent across all reported use and, when standard stimulation limits are respected, far lower than that in routine clinical care. The Mayo Clinic and Cleveland Clinic both list seizure as an uncommon but possible risk. Most documented cases occurred either before modern stimulation limits were set, in research protocols pushing intensity or frequency, or in people who already had a lowered seizure threshold.

That last group is why history matters. Established epilepsy, or a personal history of unprovoked seizures, is treated by most programs as a contraindication or a strong reason for caution, and the Mayo Clinic lists a personal or family history of seizures among the factors that may make someone unsuitable. The logic is straightforward: TMS is asking cortex that is already prone to synchronized firing to fire on cue.

Not every seizure story carries equal weight. A single febrile seizure in early childhood, a seizure during a documented alcohol withdrawal decades ago, or a fainting spell that a relative once called a fit are different from a current epilepsy diagnosis. Teams often review neurology records, sometimes request an EEG, a recording of the brain’s electrical activity, and may involve a neurologist before deciding. Some research centers study TMS in epilepsy under strict monitoring, but that remains investigational and should not be read as standard practice.

Who is TMS usually for, and who is usually asked to wait?

The clearest indication is major depressive disorder in adults that has not responded adequately to at least one course of antidepressant medication or psychotherapy, according to the Mayo Clinic and NIMH. Regulators in several countries have also cleared specific TMS protocols for obsessive-compulsive disorder, for certain anxious features of depression, for smoking cessation and, using a single-pulse device, for migraine with aura. Each of those has its own coil placement and evidence base, and a clinic offering one is not automatically equipped for another.

Being asked to wait is different from being turned down. Several situations lead teams to pause rather than proceed:

• A medical condition that is not yet stable, such as poorly controlled heart disease or a recent stroke or head injury, where a seizure would be especially dangerous.
• Active withdrawal from alcohol or sedative medicines, which temporarily lowers the seizure threshold.
• A current manic episode in bipolar disorder, since stimulation can, uncommonly, tip mood upward.
• Pregnancy, where data are limited and the discussion usually weighs alternatives first.
• Severe suicidal risk requiring faster intervention than a multi-week outpatient course can offer; in that case hospitalization or electroconvulsive therapy may be discussed.

Age is handled locally. Many programs treat adults only, although some protocols have been cleared for older adolescents in certain jurisdictions, and the treating team decides based on the specific device and indication.

People sometimes assume the ideal candidate is someone with mild symptoms. The opposite is closer to the truth: TMS is generally positioned after first-line treatments, for people whose depression has persisted despite them, and who are otherwise medically steady enough to attend daily sessions for weeks.

What disqualifies you for TMS, and what merely needs a conversation?

Screening forms vary, but they circle the same themes. Knowing why each question exists turns an interrogation into a collaboration.

Questions about metal and devices, covered above, are aimed at heating, movement and malfunction. Questions about seizures, fainting and head injury target seizure threshold. Questions about hearing exist because each pulse produces a loud click, and the safety guidelines recommend hearing protection for everyone in the room; someone with existing hearing loss or tinnitus, a persistent ringing in the ears, deserves a closer look rather than automatic exclusion. Questions about headaches distinguish ordinary tension headaches from migraines, which can be aggravated during the first week of treatment. Questions about sleep, alcohol and recreational drug use are all, at heart, seizure-threshold questions again.

Broadly, the items that most often end a candidacy outright are:

• Ferromagnetic metal or an electronic device inside the skull.
• A cochlear implant.
• An active seizure disorder that is not well controlled.

The items that usually trigger discussion rather than refusal include titanium hardware outside the treatment field, a cardiac device that cardiology confirms can be safely managed, a remote seizure with a clear provoking cause, a stable neurological condition, or a medicine that lowers seizure threshold and cannot be changed.

Honesty on the form protects you. Leaving out a piece of shrapnel because it happened long ago, or minimizing weekend drinking because it feels irrelevant to depression, removes the one safeguard designed to keep the treatment rare in its harms. Teams are not looking for reasons to say no; they are looking for the information that lets them say yes safely.

Medicines, alcohol and sleep: the quiet factors that change seizure threshold

Seizure threshold is the amount of provocation a brain needs before it produces a seizure. It is not fixed. Several everyday factors nudge it up or down, and TMS teams pay close attention to them because a lowered threshold makes the rare event slightly less rare.

Medicines come first. Certain drug classes are known to lower the threshold, including some antidepressants such as bupropion and the older tricyclics, several antipsychotics, and stimulants used for attention disorders. None of these automatically rules TMS out, and this article is not suggesting anyone alter what they take. The point is that the prescribing clinician and the TMS clinician need to know the full list, including supplements and over-the-counter products, so that stimulation intensity and monitoring can be set accordingly. Any planned medication change during a course should be announced in advance, not discovered afterward.

Withdrawal matters as much as use. Stopping alcohol, benzodiazepines or certain sleep medicines abruptly produces a rebound period during which the brain is markedly more excitable. Programs commonly ask people to avoid heavy drinking throughout treatment and to report any change in intake.

Sleep deprivation is the factor people most often overlook. A night of very little sleep measurably lowers seizure threshold, which is why some clinics ask how you slept before each session and may reschedule after a sleepless night.

Finally, acute illness with fever, and significant changes in blood sugar or electrolytes, can shift the threshold temporarily. Mentioning a flu or a new diagnosis of diabetes mid-course is not an inconvenience to staff; it is exactly the kind of update the safety framework depends on.

What are the side effects of TMS, and how do they compare with the alternatives?

Most side effects of TMS are local and short-lived. The Mayo Clinic and Cleveland Clinic list scalp discomfort or pain at the stimulation site, headache, tingling or twitching of facial muscles during the pulses, and lightheadedness. These tend to be most noticeable in the first week and often ease as people acclimate. Because the treatment does not circulate through the bloodstream, it does not produce the weight change, sexual dysfunction or gastrointestinal effects that many people associate with antidepressant medicines.

Serious effects are rare. Seizure has been discussed above. Hearing changes are possible if ear protection is skipped, which is why earplugs are standard. Manic episodes have been reported occasionally in people with bipolar disorder, and teams screen for that history. Cognitive side effects such as memory loss are not a recognized feature of TMS, which distinguishes it from electroconvulsive therapy.

Placing TMS among the alternatives helps candidacy make sense:

• Medication adjustments act on the whole body, take several weeks to show benefit, and carry systemic side effects; they remain the most common next step.
• Psychotherapy carries no physical risk and is often combined with any of the other options.
• Electroconvulsive therapy requires general anesthesia, deliberately induces a seizure under controlled conditions, and can cause temporary memory problems, but acts faster and is often preferred when risk is acute.
• Newer rapid-acting medicines given under supervision have their own eligibility rules and monitoring needs.

None of these is universally better. The right sequence depends on how urgent the situation is, what has already been tried, what your body can tolerate, and what your treating team judges most likely to help you specifically.

What do the following weeks usually look like?

A standard course is a commitment measured in weeks rather than hours. The Mayo Clinic describes daily weekday sessions for about four to six weeks, and many programs then reduce the frequency over one to three further weeks in a taper, a gradual step-down designed to consolidate any gains. Each appointment, including check-in and setup, usually fits inside an hour.

The first few days are about adjustment. The tapping can feel sharp at first, and scalp tenderness or a mild headache afterward is common; the Cleveland Clinic notes these effects generally lessen after the first week or two. Staff can adjust coil angle and, within the safety limits, intensity to improve comfort. Most people return to work, school or errands straight from the clinic.

Mood changes, when they happen, tend to arrive quietly. Some people notice small shifts in energy or sleep before they notice a shift in mood, and both the Mayo Clinic and NIMH describe benefit, where it occurs, emerging over several weeks rather than after a single session. This is a treatment for the patient, not the calendar: a slow start is not a sign of failure, and a good first week is not a guarantee.

Throughout the course, the team will ask about seizures, fainting, headaches, hearing, sleep, alcohol and any new medicines. That repetition is deliberate. Candidacy is reassessed every day you walk in, not settled once at the start.

After the course, follow-up varies. Some people continue medication or therapy that was already in place; some are offered maintenance sessions if symptoms return. What comes next is a shared decision with the treating team, informed by how you responded and how your life looks by the final session.

What is the controversy with TMS?

Ask a room of psychiatrists and you will hear a range of opinions, and that range is itself the controversy. The debate rarely concerns safety, which is well characterized. It concerns how much benefit to expect, for whom, and how the treatment is sold.

Evidence quality is the first strand. TMS for depression is supported by multiple randomized trials comparing active stimulation with a sham coil that mimics the sound and sensation without stimulating the brain. NIMH describes the evidence as supporting effectiveness for some people with treatment-resistant depression. Critics point out that trials vary in coil design, target location, pulse pattern and duration, which makes results harder to pool, and that improvement rates are meaningful but far from universal. Anyone quoting a single tidy success percentage is oversimplifying a messy literature.

Marketing is the second strand. Because TMS is delivered in outpatient clinics, some of them advertising directly to the public, promotional language sometimes outruns the data. Phrases such as “life-changing” or “no side effects” appear in advertisements more often than in guidelines. A careful clinic will describe TMS as one option among several, with a realistic chance of helping and a real chance of not helping.

The third strand is expansion. Newer protocols that compress weeks of stimulation into days, and applications to conditions beyond depression, are being adopted faster than long-term data can accumulate. Enthusiasm is understandable; caution is warranted.

None of this makes TMS a fringe treatment. Major medical centers offer it and major guidelines discuss it. It does mean that an informed patient should read claims critically, ask what evidence supports the specific protocol offered, and expect uncertainty to be acknowledged rather than glossed over.

Standard vs accelerated TMS: does the schedule change who qualifies?

Two broad scheduling approaches exist. Standard TMS delivers one session per day over several weeks, as described earlier. Accelerated protocols deliver multiple sessions per day, sometimes many, over a much shorter period, often using theta burst stimulation, a pattern of very rapid pulse clusters that mimics a natural brain rhythm and shortens each session to a few minutes.

The screening rules do not relax for speed. Metal and device checks, seizure history, medication review and hearing protection apply identically, because the physics of each pulse is unchanged. What does change is the total number of pulses delivered in a day and the intervals between sessions, and the safety guidelines treat those as variables that need justification rather than defaults that can be assumed.

Three practical differences shape candidacy:

• Someone whose seizure threshold is borderline, for example because of an unavoidable medicine, may be steered toward a standard schedule, where daily exposure is lower and any warning signs have time to surface between sessions.
• Accelerated courses demand the ability to spend most of the day at the clinic for a stretch of consecutive days, which is a logistical fit question as much as a clinical one.
• The evidence base for accelerated protocols is newer and smaller, so teams may reserve them for people who understand that long-term data are still accumulating.

Neither schedule is inherently superior for everyone. A compressed course may suit someone who cannot sustain six weeks of daily visits; a standard course may suit someone whose team wants a more gradual, observable trajectory. As with every other candidacy question, the answer comes from matching the protocol to the person, and that judgment belongs to the treating team.

What people often get wrong about TMS candidacy, metal implants and seizures

Misconceptions cluster around the screening questions, and several of them steer people either toward false reassurance or unnecessary self-exclusion.

“Any metal anywhere means no.” Distance and material decide, not the mere presence of metal. A hip replacement or a spinal rod is far outside the field. Dental work is generally acceptable. What excludes people is ferromagnetic or electronic material in or near the head.

“If I can have an MRI, I can have TMS, and vice versa.” The two overlap but are not identical. MRI exposes the whole body to a static field for many minutes; TMS exposes a small region to brief pulses. An implant labeled MRI-conditional may still need separate evaluation for TMS, and some devices safe for TMS have MRI restrictions.

“A childhood seizure permanently disqualifies me.” A single provoked seizure decades ago is weighed differently from active epilepsy. It prompts a review, not an automatic refusal.

“TMS is basically a gentler version of ECT.” They are different treatments. ECT intentionally induces a seizure under anesthesia; TMS is designed to avoid one entirely while you sit awake.

“Screening is a one-time formality.” Candidacy is checked at every visit because sleep, alcohol, illness and medicines change from week to week.

“Newer or stronger protocols must work better.” More pulses in less time is a different trade-off, not a proven upgrade, and the evidence for accelerated approaches is still maturing.

“If the clinic says I qualify, that settles it.” Qualification is a shared judgment between you, the TMS team and any specialists involved, such as a cardiologist for a pacemaker or a neurologist for a seizure history. Bringing your records and asking follow-up questions is part of the process, not a challenge to it.

Questions to ask your care team before you decide

A good consultation leaves you with fewer assumptions and more specifics. These questions are drawn from what patients most often wish they had asked.

• Which condition and which protocol are you proposing for me, and what evidence supports that specific combination?
• Given my implant or hardware, what exactly is it made of, how far is it from the coil, and who reviewed the surgical records?
• If I have a cardiac device or stimulator, has a specialist confirmed how it will be managed during sessions?
• How does my seizure history, or my family’s, change the plan, and will a neurologist be involved?
• Which of my current medicines affect seizure threshold, and how will my prescribing clinician and the TMS team coordinate?
• What side effects should I expect in the first week, and what would make you pause or stop treatment?
• How will you measure whether it is helping, and at what point would you conclude it is not?
• What happens if I miss sessions, fall ill or have a night of very poor sleep?
• What are the alternatives for someone in my situation, and why is TMS being suggested ahead of, or alongside, them?
• Who do I contact, and how quickly, if something worrying happens between appointments?

Notice that most of these are about your particular body and history rather than about TMS in general. Generic reassurance is easy to find online; individualized answers are what the consultation is for. Bring a written list of implants with dates and, if possible, the implant cards or operative notes. Bring your full medication list. Bring a partner or friend if it helps you remember what was said. The team’s job is to weigh the evidence against your specifics, and the decision, in the end, rests with them and with you together.

When to call your doctor

Most people move through a TMS course with nothing more than a tender scalp. A small number of events, however, need same-day attention, and knowing them in advance makes them easier to act on rather than second-guess.

Call emergency services immediately if you or someone with you experiences a seizure, meaning uncontrolled shaking, loss of awareness or collapse, at any point during or after a session, or if you develop sudden weakness on one side, difficulty speaking, or a severe headache unlike any you have had before.

Contact the treating team the same day if you notice any of the following:

• New or worsening thoughts of suicide or self-harm.
• A sudden lift in mood accompanied by markedly reduced need for sleep, racing thoughts or unusually impulsive behavior, which can signal a manic shift.
• Fainting or near-fainting, during or between sessions.
• Hearing loss, new ringing in the ears, or ear pain.
• Warmth, pain or a burning sensation over any implant, plate or device during stimulation.
• A headache that is severe, persists for more than a day, or does not respond to your usual approach.
• Any change in your medicines, alcohol use or health, including a fever, since your last visit.

If you have a cardiac device and feel palpitations, dizziness or notice the device behaving unusually, treat that as urgent and contact both the TMS team and your cardiology service.

None of these signs means TMS was the wrong choice. They are the reasons the screening exists and the reasons monitoring continues. Reporting them promptly lets the treating team decide whether to adjust, pause or stop, and that decision, like every other one along the way, is theirs to make with you.

Where TMS fits in a wider treatment plan

Candidacy is not only about safety. It is also about sequence: where TMS sits among the other things a person is doing to manage depression or another condition.

The NHS and NIMH both describe brain stimulation approaches as options considered when first-line treatments have not brought enough improvement. In practice that means most people arriving at a TMS consultation have already tried at least one medicine and often some form of psychotherapy. TMS is usually added to that foundation rather than replacing it. Many people continue their existing antidepressant during the course, and any decision to adjust it belongs with the prescribing clinician, who will weigh seizure threshold alongside everything else.

Psychotherapy pairs naturally with TMS. Sessions are short, leave you fully alert, and can be scheduled around therapy appointments. Some programs actively encourage continuing talk therapy through the course, since the skills learned there do not depend on any particular biological treatment working.

Lifestyle factors that influence seizure threshold, such as regular sleep and limited alcohol, happen to be the same factors that support mood, so the safety advice and the wellness advice point in the same direction.

For a minority, TMS will not be the right fit and the conversation turns elsewhere: to a different medication class, to electroconvulsive therapy when the situation is urgent, to newer supervised rapid-acting treatments, or to a more intensive program. Being told you are not a candidate for TMS closes one door, not the corridor.

Whatever the path, the person best placed to weigh it is the clinician who knows your history, your implants, your medicines and your goals. This article can explain the reasoning behind the screening form. Only your treating team can fill it in with you and decide what comes next.

Frequently asked questions

What disqualifies you for TMS?

The firmest exclusions are ferromagnetic metal or electronic devices inside or very close to the skull, such as aneurysm clips, cochlear implants, deep brain stimulators or vagus nerve stimulators, and an active seizure disorder that is not well controlled. Cardiac pacemakers and defibrillators usually require specialist review and are often excluded. Titanium hardware, remote provoked seizures and some medicines prompt discussion rather than automatic refusal. The treating team decides case by case.

Who is not a good candidate for TMS treatment?

Beyond implant and seizure exclusions, people are usually asked to wait if they have an unstable medical condition, a recent stroke or head injury, active withdrawal from alcohol or sedatives, a current manic episode, or suicidal risk severe enough to need faster intervention such as hospitalization or electroconvulsive therapy. Pregnancy generally leads to a discussion of alternatives first because data are limited. Candidacy is reassessed rather than fixed.

What is the controversy with TMS?

The debate is mainly about how much benefit to expect and how the treatment is marketed, not about safety. Trials differ in coil type, target and schedule, making results harder to pool, and improvement is meaningful for some people but far from universal. Some clinics advertise more confidently than the evidence justifies, and newer accelerated protocols are spreading faster than long-term data. Major centers offer TMS; informed skepticism about specific claims is still sensible.

How much does a TMS device or a TMS course cost?

This magazine does not publish prices, and costs vary widely by country, health system, protocol and insurance coverage, so any single figure would mislead. The useful step is to ask the clinic for a written estimate for your specific protocol and to ask your insurer what documentation of prior treatment they require, since many payers set their own candidacy criteria in addition to the medical screening described here.

Can I have TMS with dental implants, crowns or fillings?

In most cases, yes. Dental fillings, crowns, bridges and standard braces are small, fixed and sit well below the treatment area, and the Mayo Clinic lists them as generally acceptable exceptions to the metal-in-the-head rule. Tell the team anyway, especially about magnetic denture attachments or unusual dental hardware, so they can confirm the material and position rather than assume.

Can I have TMS with a titanium plate in my skull?

Possibly. Titanium is not ferromagnetic, so it will not be pulled by the coil, but heating and the plate’s distance from the treatment site still have to be assessed. Teams typically ask for the operative report to confirm the alloy and location before deciding. A plate far from the coil is treated differently from one directly beneath it, so this is a case-by-case decision rather than an automatic yes or no.

Does a childhood seizure rule out TMS? How does seizure history affect candidacy?

Not necessarily. A single febrile seizure in early childhood or a seizure clearly provoked by a specific cause is weighed differently from a current epilepsy diagnosis or repeated unprovoked seizures. Teams often review neurology records, may request an EEG, and sometimes consult a neurologist. Active or poorly controlled epilepsy is generally a contraindication; a remote provoked event usually prompts a careful discussion instead.

Is TMS safe with a pacemaker or implanted defibrillator?

Cardiac devices are a recognized concern because the magnetic pulses can interfere with their electronics, and most programs either exclude people with them or require formal cardiology review and device-specific reassurance first. Distance from the coil, the device model and whether it can be safely monitored all matter. Never assume clearance; the decision sits jointly with your cardiology team and the TMS team.

Can I drive home after a TMS session?

Usually, yes. TMS uses no anesthesia or sedation, and the Mayo Clinic notes that people can typically return to normal activities, including driving, immediately afterward. The exceptions are practical: if you feel lightheaded, have a significant headache or experienced anything unusual during the session, wait and tell staff. Anyone who has had a seizure during treatment should not drive and should follow medical and local licensing advice.

What are TMS contraindications during pregnancy?

Pregnancy is not an absolute contraindication in the safety guidelines, but data on TMS during pregnancy remain limited, so most teams discuss alternatives such as psychotherapy or medication review first and proceed only after weighing risks and benefits with obstetric input. The coil’s field reaches only a few centimeters from the head, far from the uterus, which is part of the reasoning, but caution and shared decision-making remain the norm.

References

• Cleveland Clinic: Transcranial Magnetic Stimulation (TMS)
• National Institute of Mental Health: Brain Stimulation Therapies
• NHS: Treatment – Depression in adults

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.